MidCap T ApS: Financial statements 2020
CVR: 40238581
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
MidCap T ApS (CVR 40238581) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -158,000 and a net result of DKK -32,211,000 compared with DKK -8,000 the year before. Equity in the 2020 report amounted to DKK 119,356,000. The solvency ratio was 98.1%.
- Gross Profit
- DKK -158,000
- Profit/Loss
- DKK -32,211,000
- Equity
- DKK 119,356,000
- Total Assets
- DKK 121,655,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | -158 t. | -32.2 mio. | 119.4 mio. | - |
| 2019 | - | -10 t. | -8 t. | 150.1 mio. | - |
How creditworthy is MidCap T ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
MidCap T ApS has published its interim report for the period February 6, 2019 – December 31, 2019.
About MidCap T ApS
MidCap T ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2019. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Martin Jørgensen. The board consists of Ulrik Kronborg Markussen (chair), Claus Svane Gleerup, Mads Bødtcher-Hansen and Martin Jørgensen. The company's owners include ORIFARM GENERICS HOLDING A/S, MBH ApS and Janus Investering ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -16,000 and a net result of DKK -24,871,000 compared with DKK 621,000 the year before. Equity in the 2025 report amounted to DKK 173,650,000.